MannKind | MNKD - EPS Earnings Per Share


MannKind reported $-0.02 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -0.02 -0.01 0.07 May/06
FY2025Q4 Dec/2025 0.01 0.01 0.08 Feb/26
FY2025Q3 Sep/2025 0.07 0.02 0.06 Nov/05
FY2025Q2 Jun/2025 0.05 0.05 0.05 Aug/06
FY2025Q1 Mar/2025 0.07 0.03 0.04 May/08




Eps Change Date
Adma Biologics USD 0.19 0.01 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Eli Lilly USD 8.55 1.01 Mar/2026
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Insmed USD -0.76 0.78 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
MacroGenics USD -0.58 0.36 Mar/2026
MannKind USD -0.02 0.03 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Novavax USD 0.13 0.59 Dec/2025
Novo Nordisk DKK 1.02 0.01 Dec/2025
Pfizer USD 0.75 0.09 Mar/2026
Sanofi EUR 1.88 0.35 Mar/2026
Xencor USD -1.71 1.62 Mar/2026